Recent progress of organ-on-a-chip towards cardiovascular diseases: advanced design, fabrication, and applications

Biofabrication. 2023 Jul 4;15(4). doi: 10.1088/1758-5090/acdaf9.

Abstract

Cardiovascular diseases (CVDs) are a major cause of death worldwide, leading to increased medical care costs. To turn the scale, it is essential to acquire a more in-depth and comprehensive understanding of CVDs and thus formulate more efficient and reliable treatments. Over the last decade, tremendous effort has been made to develop microfluidic systems to recapitulate native cardiovascular environments because of their unique advantages over conventional 2D culture systems and animal models such as high reproductivity, physiological relevance, and good controllability. These novel microfluidic systems could be extensively adopted for natural organ simulation, disease modeling, drug screening, disease diagnosis and therapy. Here, a brief review of the innovative designs of microfluidic devices for CVDs research is presented, with specific discussions on material selection, critical physiological and physical considerations. In addition, we elaborate on various biomedical applications of these microfluidic systems such as blood-vessel-on-a-chip and heart-on-a-chip, which are conducive to the investigation of the underlying mechanisms of CVDs. This review also provides systematic guidance on the construction of next-generation microfluidic systems for the diagnosis and treatment of CVDs. Finally, the challenges and future directions in this field are highlighted and discussed.

Keywords: blood-vessel-on-a-chip; cardiovascular diseases; heart-on-a-chip; microfluidics; organ-on-a-chip.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / therapy
  • Heart
  • Lab-On-A-Chip Devices
  • Microfluidics
  • Microphysiological Systems